当前位置: X-MOL 学术J. Pediatr. Surg. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The Use of a High Flow PICC Catheter for Stem Cell and Lymphocyte Apheresis: The Initial Experience of a Pediatric Oncology Center in Brazil
Journal of Pediatric Surgery ( IF 2.4 ) Pub Date : 2024-02-24 , DOI: 10.1016/j.jpedsurg.2024.02.022
Vilani Kremer , Andréia Rheinheimer , Ana Luiza Rodrigues , Andressa Taborda , Robson Coelho , Antonella Zanette

Autologous hematopoietic stem cell transplant (HSCT), characterized by high intensity chemotherapy followed by the infusion of HSC previously collected from the peripheral blood, is a procedure used in the treatment of several malignancies. In pediatrics, the apheresis procedure represents a challenge, due to the need for insertion of a rigid central venous catheter (CVC) in small children. The CVC is usually used for stem cell collection and then removed. Later, the patient will need a new device for cell infusion. We propose the use of one single catheter for both apheresis and infusion. We present five children between 1 and 13 years of age who underwent apheresis using a high flow PICC catheter surgically inserted. All patients utilized a PICC line double lumen 5Fr (PowerPICC™ 5Fr DL BARD/USA) placed in the brachiocephalic vein tunneled on the chest, inserted under 24 h prior to apheresis to assure the devices were pervious. Three of the patients were diagnosed with solid tumor and one with acute lymphoblastic leukemia (ALL) awaiting Car-T Cell therapy. The four children who underwent autologous HSCT used the same catheter for cell infusion and remained with the catheter following discharge. The child who was submitted for Car-T Cell still awaits infusion and the catheter was removed. High flow PICC is a viable alternative for apheresis to maintain an adequate flow of 5 ml/s and can be used as a single catheter throughout the HSCT process, reducing the risks from anesthesia and the catheter insertion procedure. Clinical Research.

中文翻译:

使用高流量 PICC 导管进行干细胞和淋巴细胞分离术:巴西儿科肿瘤中心的初步经验

自体造血干细胞移植 (HSCT) 的特点是高强度化疗,然后输注先前从外周血中收集的 HSC,是一种用于治疗多种恶性肿瘤的手术。在儿科领域,由于需要在幼儿中插入坚硬的中心静脉导管 (CVC),因此血浆分离术是一项挑战。 CVC通常用于干细胞采集,然后取出。之后,患者将需要新的细胞输注设备。我们建议使用一根导管进行血浆分离术和输注。我们介绍了 5 名 1 至 13 岁的儿童,他们使用手术插入的高流量 PICC 导管进行了血浆分离术。所有患者均使用 PICC 线双腔 5Fr (PowerPICC™ 5Fr DL BARD/USA) 放置在胸部隧道的头臂静脉中,在血浆分离术前 24 小时内插入,以确保装置可渗透。其中三名患者被诊断患有实体瘤,一名患者被诊断患有急性淋巴细胞白血病(ALL),正在等待 Car-T 细胞治疗。接受自体 HSCT 的四名儿童使用同一导管进行细胞输注,并在出院后仍保留该导管。接受 Car-T 细胞治疗的孩子仍在等待输注,导管已被移除。高流量 PICC 是单采术的可行替代方案,可维持 5 ml/s 的足够流量,并且可在整个 HSCT 过程中用作单根导管,从而降低麻醉和导管插入过程的风险。临床研究。
更新日期:2024-02-24
down
wechat
bug